1. Home
  2. |Professionals
  3. |Jon O'Connell

Jon O'Connell

Partner
Partner
am9jb25uZWxsQGNyb3dlbGwuY29tIA==
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Jon O'Connell is a co-lead of the Emerging Companies and Venture Capital practice, a partner in the Corporate Group and a resident in the firm's San Francisco office. He advises startup clients on matters related to corporate governance, venture capital financings, commercial transactions, and mergers and acquisitions. He also represents venture capital funds in equity financings.

Prior to joining the firm, Jon was an early employee and partner at a legal services and technology company providing startups with support to grow and scale their operations. He managed one of the most active venture capital financing teams in the industry having completed over 100 preferred stock equity financings. During his legal career at Am Law 100 firms, he has acted as outside general counsel for hundreds of startups in industries ranging from food tech to fintech.

Career & Education

|

    • University of California, Santa Barbara, B.A., 2008
    • Santa Clara University School of Law, J.D., 2011
    • University of California, Santa Barbara, B.A., 2008
    • Santa Clara University School of Law, J.D., 2011

    • California
    • California

Jon's Insights

Firm News | 1 min read | 11.08.24

Crowell & Moring Represents Marshall Wace as Lead Investor in Inquis Medical’s $40 Million Series B Financing

San Francisco – November 8, 2024:  Marshall Wace led Inquis Medical’s oversubscribed $40 million Series B round, along with participation from existing investors, including ShangBay Capital, Yu Star, EnPointe Ventures, and Pierre Lamond.

View All Insights

Insights

Firm News | 1 min read | 11.08.24

Crowell & Moring Represents Marshall Wace as Lead Investor in Inquis Medical’s $40 Million Series B Financing

Firm News | 1 min read | 10.31.24

Crowell Represents Nuclear Energy Startup Antares Industries in $30M Series A

Press Coverage | 06.03.24

Liquidation Preferences, Other Types Of Structure Remain Persistent In VC Rounds In 2024

Press Coverage | 05.21.24

Lack Of Exits, Lower VC Valuations Are Driving A Late-Stage Lull
|

View All Insights

Practices

Industries

Jon's Insights

Firm News | 1 min read | 11.08.24

Crowell & Moring Represents Marshall Wace as Lead Investor in Inquis Medical’s $40 Million Series B Financing

San Francisco – November 8, 2024:  Marshall Wace led Inquis Medical’s oversubscribed $40 million Series B round, along with participation from existing investors, including ShangBay Capital, Yu Star, EnPointe Ventures, and Pierre Lamond.

View All Insights